抗肿瘤药-话题@MedSci

#抗肿瘤药#

85篇内容 | 2887人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1593682, encodeId=1b7b1593682c1, content=<a href='/topic/show?id=ff895565586' target=_blank style='color:#2F92EE;'>#抗肿瘤药#</a>, objectTitle=JAMA Intern Med：抗肿瘤药物研发成本研究, objectType=article, longId=112666, objectId=076d1126667c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=076d1126667c, replyNumber=0, likeNumber=76, createdTime=2017-09-14, rootId=0, userName=zhu_jun9843, userId=aa5e18156549, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=076d1126667c, moduleTitle=JAMA Intern Med：抗肿瘤药物研发成本研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=076d1126667c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1593681, encodeId=b1c0159368136, content=<a href='/topic/show?id=ff895565586' target=_blank style='color:#2F92EE;'>#抗肿瘤药#</a>, objectTitle=CFDA官网干货：抗肿瘤药物临床试验重要终点指标, objectType=article, longId=111435, objectId=4859111435d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4859111435d4, replyNumber=0, likeNumber=92, createdTime=2017-09-01, rootId=0, userName=zhu_jun9843, userId=aa5e18156549, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4859111435d4, moduleTitle=CFDA官网干货：抗肿瘤药物临床试验重要终点指标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4859111435d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1593680, encodeId=853815936804f, content=<a href='/topic/show?id=ff895565586' target=_blank style='color:#2F92EE;'>#抗肿瘤药#</a>, objectTitle=2022年畅销的抗肿瘤药物TOP10, objectType=article, longId=101362, objectId=72d610136280, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=72d610136280, replyNumber=0, likeNumber=66, createdTime=2017-06-11, rootId=0, userName=zhu_jun9843, userId=aa5e18156549, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=72d610136280, moduleTitle=2022年畅销的抗肿瘤药物TOP10, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=72d610136280)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1593679, encodeId=4f5115936e9f2, content=<a href='/topic/show?id=ff895565586' target=_blank style='color:#2F92EE;'>#抗肿瘤药#</a>, objectTitle=Sci Rep：朱诗国团队提出抗肿瘤药物研发的新思路, objectType=article, longId=98001, objectId=8db298001d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8db298001d9, replyNumber=0, likeNumber=73, createdTime=2017-05-07, rootId=0, userName=zhu_jun9843, userId=aa5e18156549, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8db298001d9, moduleTitle=Sci Rep：朱诗国团队提出抗肿瘤药物研发的新思路, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8db298001d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1593678, encodeId=7cb915936e8a7, content=<a href='/topic/show?id=ff895565586' target=_blank style='color:#2F92EE;'>#抗肿瘤药#</a>, objectTitle=抗肿瘤药物的时间“罗盘”, objectType=article, longId=92210, objectId=eec192210cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eec192210cb, replyNumber=0, likeNumber=87, createdTime=2017-03-19, rootId=0, userName=zhu_jun9843, userId=aa5e18156549, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eec192210cb, moduleTitle=抗肿瘤药物的时间“罗盘”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eec192210cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1593677, encodeId=958d15936e74c, content=<a href='/topic/show?id=ff895565586' target=_blank style='color:#2F92EE;'>#抗肿瘤药#</a>, objectTitle=【数图说】国内外抗肿瘤药销售市场一览, objectType=article, longId=88816, objectId=a4ee888166c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a4ee888166c, replyNumber=0, likeNumber=66, createdTime=2017-02-16, rootId=0, userName=zhu_jun9843, userId=aa5e18156549, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a4ee888166c, moduleTitle=【数图说】国内外抗肿瘤药销售市场一览, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a4ee888166c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1593676, encodeId=3b6915936e6a4, content=<a href='/topic/show?id=ff895565586' target=_blank style='color:#2F92EE;'>#抗肿瘤药#</a>, objectTitle=The Lancent oncology：所有仿制的抗肿瘤药都安全吗？, objectType=article, longId=82021, objectId=25f182021e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=25f182021e4, replyNumber=0, likeNumber=61, createdTime=2016-11-11, rootId=0, userName=zhu_jun9843, userId=aa5e18156549, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=25f182021e4, moduleTitle=The Lancent oncology：所有仿制的抗肿瘤药都安全吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=25f182021e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1593675, encodeId=be6815936e5ba, content=<a href='/topic/show?id=ff895565586' target=_blank style='color:#2F92EE;'>#抗肿瘤药#</a>, objectTitle=NEJM：抗肿瘤药心脏毒性十五要点, objectType=article, longId=81980, objectId=cc11819802a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cc11819802a, replyNumber=0, likeNumber=80, createdTime=2016-11-10, rootId=0, userName=zhu_jun9843, userId=aa5e18156549, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cc11819802a, moduleTitle=NEJM：抗肿瘤药心脏毒性十五要点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cc11819802a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1593674, encodeId=854f15936e4d9, content=<a href='/topic/show?id=ff895565586' target=_blank style='color:#2F92EE;'>#抗肿瘤药#</a>, objectTitle=2016MASCC/ESMO共识建议——催吐药风险分类及抗肿瘤药物致吐性评估发布, objectType=article, longId=76273, objectId=3d4be6273e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d4be6273e6, replyNumber=0, likeNumber=39, createdTime=2016-09-01, rootId=0, userName=zhu_jun9843, userId=aa5e18156549, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d4be6273e6, moduleTitle=2016MASCC/ESMO共识建议——催吐药风险分类及抗肿瘤药物致吐性评估发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3d4be6273e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1593673, encodeId=502515936e3b0, content=<a href='/topic/show?id=ff895565586' target=_blank style='color:#2F92EE;'>#抗肿瘤药#</a>, objectTitle=未来5年畅销的抗肿瘤药物TOP10, objectType=article, longId=75388, objectId=e37be538834, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e37be538834, replyNumber=0, likeNumber=51, createdTime=2016-08-19, rootId=0, userName=zhu_jun9843, userId=aa5e18156549, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e37be538834, moduleTitle=未来5年畅销的抗肿瘤药物TOP10, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e37be538834)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1593672, encodeId=869415936e231, content=<a href='/topic/show?id=ff895565586' target=_blank style='color:#2F92EE;'>#抗肿瘤药#</a>, objectTitle=复旦大学抗肿瘤药物专利“天价”卖给美国公司, objectType=article, longId=64929, objectId=dfc664929a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dfc664929a1, replyNumber=0, likeNumber=94, createdTime=2016-03-18, rootId=0, userName=zhu_jun9843, userId=aa5e18156549, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dfc664929a1, moduleTitle=复旦大学抗肿瘤药物专利“天价”卖给美国公司, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dfc664929a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1593671, encodeId=ba3315936e1d8, content=<a href='/topic/show?id=ff895565586' target=_blank style='color:#2F92EE;'>#抗肿瘤药#</a>, objectTitle=JAMA Dermat：在美国，局部抗肿瘤药物涨幅近1240%, objectType=article, longId=59536, objectId=03c459536ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=03c459536ba, replyNumber=0, likeNumber=107, createdTime=2015-11-28, rootId=0, userName=zhu_jun9843, userId=aa5e18156549, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=03c459536ba, moduleTitle=JAMA Dermat：在美国，局部抗肿瘤药物涨幅近1240%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=03c459536ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1593670, encodeId=b68315936e0a5, content=<a href='/topic/show?id=ff895565586' target=_blank style='color:#2F92EE;'>#抗肿瘤药#</a>, objectTitle=抗肿瘤药物尼罗替尼可能会逆转帕金森氏症, objectType=article, longId=57761, objectId=a0445e76182, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a0445e76182, replyNumber=0, likeNumber=51, createdTime=2015-10-26, rootId=0, userName=zhu_jun9843, userId=aa5e18156549, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a0445e76182, moduleTitle=抗肿瘤药物尼罗替尼可能会逆转帕金森氏症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a0445e76182)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1593669, encodeId=1da1159366989, content=<a href='/topic/show?id=ff895565586' target=_blank style='color:#2F92EE;'>#抗肿瘤药#</a>, objectTitle=Sci China Materials：常用抗肿瘤药物顺铂耐药性研究的新发现, objectType=article, longId=57302, objectId=3c895e302cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c895e302cd, replyNumber=0, likeNumber=67, createdTime=2015-10-17, rootId=0, userName=zhu_jun9843, userId=aa5e18156549, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c895e302cd, moduleTitle=Sci China Materials：常用抗肿瘤药物顺铂耐药性研究的新发现, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3c895e302cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1593668, encodeId=8e351593668c1, content=<a href='/topic/show?id=ff895565586' target=_blank style='color:#2F92EE;'>#抗肿瘤药#</a>, objectTitle=礼来要拿4亿美元与信达生物合作开发抗肿瘤药, objectType=article, longId=48578, objectId=b649485e899, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b649485e899, replyNumber=0, likeNumber=63, createdTime=2015-03-26, rootId=0, userName=zhu_jun9843, userId=aa5e18156549, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b649485e899, moduleTitle=礼来要拿4亿美元与信达生物合作开发抗肿瘤药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b649485e899)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1593667, encodeId=699a159366efb, content=<a href='/topic/show?id=ff895565586' target=_blank style='color:#2F92EE;'>#抗肿瘤药#</a>, objectTitle=2014年FDA新批准的抗肿瘤药物, objectType=article, longId=46897, objectId=ef0f4689eb5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ef0f4689eb5, replyNumber=0, likeNumber=66, createdTime=2015-02-12, rootId=0, userName=zhu_jun9843, userId=aa5e18156549, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ef0f4689eb5, moduleTitle=2014年FDA新批准的抗肿瘤药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ef0f4689eb5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1593666, encodeId=ec6a159366658, content=<a href='/topic/show?id=ff895565586' target=_blank style='color:#2F92EE;'>#抗肿瘤药#</a>, objectTitle=Int Arch Occ Env HEA：加拿大卫生保健工作者暴露于抗肿瘤药物的风险因素, objectType=article, longId=46487, objectId=cb004648ea2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cb004648ea2, replyNumber=0, likeNumber=61, createdTime=2015-02-04, rootId=0, userName=zhu_jun9843, userId=aa5e18156549, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cb004648ea2, moduleTitle=Int Arch Occ Env HEA：加拿大卫生保健工作者暴露于抗肿瘤药物的风险因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cb004648ea2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1593665, encodeId=5fd61593665f4, content=<a href='/topic/show?id=ff895565586' target=_blank style='color:#2F92EE;'>#抗肿瘤药#</a>, objectTitle=靶向抗肿瘤药物的命名, objectType=article, longId=46320, objectId=1bec4632027, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1bec4632027, replyNumber=0, likeNumber=70, createdTime=2015-01-30, rootId=0, userName=zhu_jun9843, userId=aa5e18156549, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1bec4632027, moduleTitle=靶向抗肿瘤药物的命名, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1bec4632027)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1593664, encodeId=0b6c159366493, content=<a href='/topic/show?id=ff895565586' target=_blank style='color:#2F92EE;'>#抗肿瘤药#</a>, objectTitle=Cell Res：抗肿瘤药物可维持胚胎干细胞的自我更新, objectType=article, longId=40353, objectId=a9d940353d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a9d940353d8, replyNumber=0, likeNumber=74, createdTime=2014-09-18, rootId=0, userName=zhu_jun9843, userId=aa5e18156549, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a9d940353d8, moduleTitle=Cell Res：抗肿瘤药物可维持胚胎干细胞的自我更新, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a9d940353d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1593663, encodeId=91ac1593663b2, content=<a href='/topic/show?id=ff895565586' target=_blank style='color:#2F92EE;'>#抗肿瘤药#</a>, objectTitle=十三大类抗肿瘤药物靶点汇总, objectType=article, longId=35421, objectId=a78b35421f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a78b35421f9, replyNumber=0, likeNumber=85, createdTime=2014-05-28, rootId=0, userName=zhu_jun9843, userId=aa5e18156549, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a78b35421f9, moduleTitle=十三大类抗肿瘤药物靶点汇总, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a78b35421f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

抗肿瘤药

2020-05-29

zhu_jun9843 (审核中...)

前往app查看评论内容

#抗肿瘤药#

JAMA Intern Med：抗肿瘤药物研发成本研究

2017-09-14

zhu_jun9843 (审核中...)

前往app查看评论内容

#抗肿瘤药#

CFDA官网干货：抗肿瘤药物临床试验重要终点指标

2017-09-01

zhu_jun9843 (审核中...)

前往app查看评论内容

#抗肿瘤药#

2022年畅销的抗肿瘤药物TOP10

2017-06-11

zhu_jun9843 (审核中...)

前往app查看评论内容

#抗肿瘤药#

Sci Rep：朱诗国团队提出抗肿瘤药物研发的新思路

2017-05-07

zhu_jun9843 (审核中...)

前往app查看评论内容

#抗肿瘤药#

抗肿瘤药物的时间“罗盘”

2017-03-19

zhu_jun9843 (审核中...)

前往app查看评论内容

#抗肿瘤药#

【数图说】国内外抗肿瘤药销售市场一览

2017-02-16

zhu_jun9843 (审核中...)

前往app查看评论内容

#抗肿瘤药#

The Lancent oncology：所有仿制的抗肿瘤药都安全吗？

2016-11-11

zhu_jun9843 (审核中...)

前往app查看评论内容

#抗肿瘤药#

NEJM：抗肿瘤药心脏毒性十五要点

2016-11-10

zhu_jun9843 (审核中...)

前往app查看评论内容

#抗肿瘤药#

2016MASCC/ESMO共识建议——催吐药风险分类及抗肿瘤药物致吐性评估发布

2016-09-01

zhu_jun9843 (审核中...)

前往app查看评论内容

#抗肿瘤药#

未来5年畅销的抗肿瘤药物TOP10

2016-08-19

zhu_jun9843 (审核中...)

前往app查看评论内容

#抗肿瘤药#

复旦大学抗肿瘤药物专利“天价”卖给美国公司

2016-03-18

zhu_jun9843 (审核中...)

前往app查看评论内容

#抗肿瘤药#

JAMA Dermat：在美国，局部抗肿瘤药物涨幅近1240%

2015-11-28

zhu_jun9843 (审核中...)

前往app查看评论内容

#抗肿瘤药#

抗肿瘤药物尼罗替尼可能会逆转帕金森氏症

2015-10-26

zhu_jun9843 (审核中...)

前往app查看评论内容

#抗肿瘤药#

Sci China Materials：常用抗肿瘤药物顺铂耐药性研究的新发现

2015-10-17

zhu_jun9843 (审核中...)

前往app查看评论内容

#抗肿瘤药#

礼来要拿4亿美元与信达生物合作开发抗肿瘤药

2015-03-26

zhu_jun9843 (审核中...)

前往app查看评论内容

#抗肿瘤药#

2014年FDA新批准的抗肿瘤药物

2015-02-12

zhu_jun9843 (审核中...)

前往app查看评论内容

#抗肿瘤药#

Int Arch Occ Env HEA：加拿大卫生保健工作者暴露于抗肿瘤药物的风险因素

2015-02-04

zhu_jun9843 (审核中...)

前往app查看评论内容

#抗肿瘤药#

靶向抗肿瘤药物的命名

2015-01-30

zhu_jun9843 (审核中...)

前往app查看评论内容

#抗肿瘤药#

Cell Res：抗肿瘤药物可维持胚胎干细胞的自我更新

2014-09-18

zhu_jun9843 (审核中...)

前往app查看评论内容

#抗肿瘤药#

十三大类抗肿瘤药物靶点汇总

2014-05-28

科室
- - 订阅+
  - 更多科室
工具
服务